Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434092 | 1.00 | AKT1 (0.46) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL24766030 | 0.76 | KMT2A (0.47) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL244072 | 0.75 | PIK3CA (0.47) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL29434078 | 0.75 | PIK3CA (0.47) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL242170 | 0.74 | KMO (0.56) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL17204101 | 0.74 | MAPT (0.61) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL24766540 | 0.74 | AKT1 (0.45) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL24766575 | 0.74 | AKT1 (0.45) | AKT1PIK3CAKMT2AMEN1NPC1 | |
| SCHEMBL5214322 | 0.73 | PIK3CA (0.56) | AKT1PIK3CAKDM4EMAPTTSHR | |
| SCHEMBL913213 | 0.73 | KMT2A (0.63) | KMT2AMEN1NPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340543-A1 | INHIBITORS OF RAF KINASES | Pierre Fabre Médicament (FR) | 2022-10-27 | — | — | US | disclosed |
| US-11407737-B2 | Inhibitors of RAF kinases | KINNATE BIOPHARMA INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-11407737-B2 | Inhibitors of RAF kinases | KINNATE BIOPHARMA INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-20220089569-A1 | INHIBITORS OF RAF KINASES | Pierre Fabre Médicament (FR) | 2022-03-24 | — | — | US | disclosed |
| WO-2022060996-A1 | INHIBITORS OF RAF KINASES | KINNATE BIOPHARMA INC. (US) | 2022-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340543-A1 | INHIBITORS OF RAF KINASES | BRAF, RAF1, ARAF | AKT1 38/4885PIK3CA 61/4885KMT2A 1631/4885 |
| US-11407737-B2 | Inhibitors of RAF kinases | BRAF, RAF1, ARAF | AKT1 38/4885PIK3CA 61/4885KMT2A 1631/4885 |
| US-20220089569-A1 | INHIBITORS OF RAF KINASES | BRAF, RAF1, ARAF | AKT1 38/4885PIK3CA 61/4885KMT2A 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.